Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 852126, 12 pages
http://dx.doi.org/10.1155/2015/852126
Research Article

Effect of Weight-Reduction in Obese Mice Lacking Toll-Like Receptor 5 and C57BL/6 Mice Fed a Low-Fat Diet

1Department of Anesthesiology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Taoyuan City, Taiwan
2Department of Neurosurgery, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Taoyuan City, Taiwan
3Department of Plastic and Reconstructive Surgery, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Taoyuan City, Taiwan

Received 27 July 2015; Revised 20 October 2015; Accepted 25 October 2015

Academic Editor: Luca Cantarini

Copyright © 2015 Shao-Chun Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. M. L. Tsukumo, M. A. Carvalho-Filho, J. B. C. Carvalheira et al., “Loss-of-function mutation in toll-like receptor 4 prevents diet-induced obesity and insulin resistance,” Diabetes, vol. 56, no. 8, pp. 1986–1998, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Monteiro and I. Azevedo, “Chronic inflammation in obesity and the metabolic syndrome,” Mediators of Inflammation, vol. 2010, Article ID 289645, 10 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Betanzos-Cabrera, D. Estrada-Luna, H. Belefant-Miller, and J. C. Cancino-Diaz, “Mice fed with a high fat diet show a decrease in the expression of ‘toll like receptor (TLR)2 and TLR6 mRNAs in adipose and hepatic tissues,” Nutricion Hospitalaria, vol. 27, no. 4, pp. 1196–1203, 2012. View at Google Scholar
  4. A. Schäffler, J. Schölmerich, and B. Salzberger, “Adipose tissue as an immunological organ: Toll-like receptors, C1q/TNFs and CTRPs,” Trends in Immunology, vol. 28, no. 9, pp. 393–399, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Pietsch, A. Batra, T. Stroh et al., “Toll-like receptor expression and response to specific stimulation in adipocytes and preadipocytes: on the role of fat in inflammation,” Annals of the New York Academy of Sciences, vol. 1072, pp. 407–409, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Batra, J. Pietsch, I. Fedke et al., “Leptin-dependent toll-like receptor expression and responsiveness in preadipocytes and adipocytes,” The American Journal of Pathology, vol. 170, no. 6, pp. 1931–1941, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. S.-J. Kim, Y. Choi, Y.-H. Choi, and T. Park, “Obesity activates toll-like receptor-mediated proinflammatory signaling cascades in the adipose tissue of mice,” Journal of Nutritional Biochemistry, vol. 23, no. 2, pp. 113–122, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Podrini, E. L. Cambridge, C. J. Lelliott et al., “High-fat feeding rapidly induces obesity and lipid derangements in C57BL/6N mice,” Mammalian Genome, vol. 24, no. 5-6, pp. 240–251, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Collins, T. L. Martin, R. S. Surwit, and J. Robidoux, “Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics,” Physiology and Behavior, vol. 81, no. 2, pp. 243–248, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. R. S. Surwit, C. M. Kuhn, C. Cochrane, J. A. McCubbin, and M. N. Feinglos, “Diet-induced type II diabetes in C57BL/6J mice,” Diabetes, vol. 37, no. 9, pp. 1163–1167, 1988. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Tilg, “Obesity, metabolic syndrome and microbiota: multiple interactions,” Journal of Clinical Gastroenterology, vol. 44, supplement 1, pp. S16–S18, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Ding and P. K. Lund, “Role of intestinal inflammation as an early event in obesity and insulin resistance,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 14, no. 4, pp. 328–333, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Vijay-Kumar, J. D. Aitken, F. A. Carvalho et al., “Metabolic syndrome and altered gut microbiota in mice lacking toll-like receptor 5,” Science, vol. 328, no. 5975, pp. 228–231, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. N. M. Al-Daghri, M. Clerici, O. Al-Attas et al., “A nonsense polymorphism (R392X) in TLR5 protects from obesity but predisposes to diabetes,” Journal of Immunology, vol. 190, no. 7, pp. 3716–3720, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Sartipy and D. J. Loskutoff, “Monocyte chemoattractant protein 1 in obesity and insulin resistance,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 12, pp. 7265–7270, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. E. P. Weiss, S. B. Racette, D. T. Villareal et al., “Improvements in glucose tolerance and insulin action induced by increasing energy expenditure or decreasing energy intake: a randomized controlled trial,” The American Journal of Clinical Nutrition, vol. 84, no. 5, pp. 1033–1042, 2006. View at Google Scholar · View at Scopus
  17. M. Muurling, M. C. Jong, R. P. Mensink et al., “A low-fat diet has a higher potential than energy restriction to improve high-fat diet-induced insulin resistance in mice,” Metabolism: Clinical and Experimental, vol. 51, no. 6, pp. 695–701, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. F. P. M. Hoevenaars, J. Keijer, L. Herreman et al., “Adipose tissue metabolism and inflammation are differently affected by weight loss in obese mice due to either a high-fat diet restriction or change to a low-fat diet,” Genes & Nutrition, vol. 9, no. 3, article 391, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Bertin, P. Nguyen, M. Guenounou, V. Durlach, G. Potron, and M. Leutenegger, “Plasma levels of tumor necrosis factor-alpha (TNF-α) are essentially dependent on visceral fat amount in type 2 diabetic patients,” Diabetes & Metabolism, vol. 26, no. 3, pp. 178–182, 2000. View at Google Scholar · View at Scopus
  20. T. You, B. J. Nicklas, J. Ding et al., “The metabolic syndrome is associated with circulating adipokines in older adults across a wide range of adiposity,” Journals of Gerontology A Biological Sciences and Medical Sciences, vol. 63, no. 4, pp. 414–419, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Gnacińska, S. Małgorzewicz, M. Stojek, W. Łysiak-Szydłowska, and K. Sworczak, “Role of adipokines in complications related to obesity: a review,” Advances in Medical Sciences, vol. 54, no. 2, pp. 150–157, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Monteiro, P. M. S. T. de Castro, C. Calhau, and I. Azevedo, “Adipocyte size and liability to cell death,” Obesity Surgery, vol. 16, no. 6, pp. 804–806, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Gao, Y. Ma, D. Liu, and K. Stadler, “High-fat diet-induced adiposity, adipose inflammation, hepatic steatosis and hyperinsulinemia in outbred CD-1 mice,” PLoS ONE, vol. 10, no. 3, Article ID e0119784, 2015. View at Publisher · View at Google Scholar
  24. Y. Wu, T. Wu, J. Wu et al., “Chronic inflammation exacerbates glucose metabolism disorders in C57BL/6J mice fed with high-fat diet,” Journal of Endocrinology, vol. 219, no. 3, pp. 195–204, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. J. M. Olefsky and C. K. Glass, “Macrophages, inflammation, and insulin resistance,” Annual Review of Physiology, vol. 72, pp. 219–246, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. D. L. Ballor and E. T. Poehlman, “Exercise-training enhances fat-free mass preservation during diet-induced weight loss: a meta-analytical finding,” International Journal of Obesity, vol. 18, no. 1, pp. 35–40, 1994. View at Google Scholar · View at Scopus
  27. O. González, C. Tobia, J. L. Ebersole, and M. J. Novak, “Caloric restriction and chronic inflammatory diseases,” Oral Diseases, vol. 18, no. 1, pp. 16–31, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. L. M. Redman and E. Ravussin, “Caloric restriction in humans: impact on physiological, psychological, and behavioral outcomes,” Antioxidants & Redox Signaling, vol. 14, no. 2, pp. 275–287, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Ye and J. N. Keller, “Regulation of energy metabolism by inflammation: a feedback response in obesity and calorie restriction,” Aging, vol. 2, no. 6, pp. 361–368, 2010. View at Google Scholar · View at Scopus
  30. V. D. Dixit, E. M. Schaffer, R. S. Pyle et al., “Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells,” The Journal of Clinical Investigation, vol. 114, no. 1, pp. 57–66, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. D. D. Taub, “Neuroendocrine interactions in the immune system,” Cellular Immunology, vol. 252, no. 1-2, pp. 1–6, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. D. D. Taub, “Novel connections between the neuroendocrine and immune systems: the ghrelin immunoregulatory network,” Vitamins and Hormones, vol. 77, pp. 325–346, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. M. C. Alessi, F. Peiretti, P. Morange, M. Henry, G. Nalbone, and I. Juhan-Vague, “Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease,” Diabetes, vol. 46, no. 5, pp. 860–867, 1997. View at Publisher · View at Google Scholar · View at Scopus
  34. I. Mertens and L. F. Van Gaal, “Obesity, haemostasis and the fibrinolytic system,” Obesity Reviews, vol. 3, no. 2, pp. 85–101, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Michalska, I. Iwan-Zietek, W. Gnilka et al., “PAI-1 and α2-AP in patients with morbid obesity,” Advances in Clinical and Experimental Medicine, vol. 22, no. 6, pp. 801–807, 2013. View at Google Scholar
  36. D. J. Schneider and B. E. Sobel, “PAI-1 and diabetes: a journey from the bench to the bedside,” Diabetes Care, vol. 35, no. 10, pp. 1961–1967, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Vague, I. Juhan-Vague, M. F. Aillaud et al., “Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects,” Metabolism, vol. 35, no. 3, pp. 250–253, 1986. View at Publisher · View at Google Scholar · View at Scopus
  38. L. M. Belalcazar, C. M. Ballantyne, W. Lang et al., “Metabolic factors, adipose tissue, and plasminogen activator inhibitor-1 levels in type 2 diabetes: findings from the look AHEAD study,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 7, pp. 1689–1695, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. A. R. Folsom, H. T. Qamhieh, R. R. Wing et al., “Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 13, no. 2, pp. 162–169, 1993. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Bo, R. Gambino, A. Pagani et al., “Relationships between human serum resistin, inflammatory markers and insulin resistance,” International Journal of Obesity, vol. 29, no. 11, pp. 1315–1320, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. M. P. Reilly, M. Lehrke, M. L. Wolfe, A. Rohatgi, M. A. Lazar, and D. J. Rader, “Resistin is an inflammatory marker of atherosclerosis in humans,” Circulation, vol. 111, no. 7, pp. 932–939, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Bokarewa, I. Nagaev, L. Dahlberg, U. Smith, and A. Tarkowski, “Resistin, an adipokine with potent proinflammatory properties,” The Journal of Immunology, vol. 174, no. 9, pp. 5789–5795, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. P. G. McTernan, C. M. Kusminski, and S. Kumar, “Resistin,” Current Opinion in Lipidology, vol. 17, no. 2, pp. 170–175, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. C. M. Steppan and M. A. Lazar, “The current biology of resistin,” Journal of Internal Medicine, vol. 255, no. 4, pp. 439–447, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Baranova, S. J. Gowder, K. Schlauch et al., “Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance,” Obesity Surgery, vol. 16, no. 9, pp. 1118–1125, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Nakata, T. Okada, K. Ozawa, and T. Yada, “Resistin induces insulin resistance in pancreatic islets to impair glucose-induced insulin release,” Biochemical and Biophysical Research Communications, vol. 353, no. 4, pp. 1046–1051, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. M. G. Netea, L. A. B. Joosten, E. Lewis et al., “Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance,” Nature Medicine, vol. 12, no. 6, pp. 650–656, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. R. Stienstra, L. A. B. Joosten, T. Koenen et al., “The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity,” Cell Metabolism, vol. 12, no. 6, pp. 593–605, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. X. Wang, N. Ota, P. Manzanillo et al., “Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes,” Nature, vol. 514, no. 7521, pp. 237–241, 2014. View at Google Scholar · View at Scopus
  50. M. M. Wolfe and M. O. Boylan, “Obesity and the gastrointestinal tract: you are what you eat,” Journal of Clinical Gastroenterology, vol. 48, no. 10, pp. 817–822, 2014. View at Google Scholar · View at Scopus
  51. R. E. Ley, P. J. Turnbaugh, S. Klein, and J. I. Gordon, “Microbial ecology: human gut microbes associated with obesity,” Nature, vol. 444, no. 7122, pp. 1022–1023, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. P. J. Turnbaugh, R. E. Ley, M. A. Mahowald, V. Magrini, E. R. Mardis, and J. I. Gordon, “An obesity-associated gut microbiome with increased capacity for energy harvest,” Nature, vol. 444, no. 7122, pp. 1027–1031, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. E. A. Murphy, K. T. Velazquez, and K. M. Herbert, “Influence of high-fat diet on gut microbiota: a driving force for chronic disease risk,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 18, no. 5, pp. 515–520, 2015. View at Publisher · View at Google Scholar